Marcus Semien Diagnosed With Grade 3 Left Hip Flexor Strain, Expected to Miss Extended Time

The Mets may be forced to operate without Marcus Semien for an extended period after a report said the infielder has been diagnosed with a Grade 3 strain of his left hip flexor. The designation matters because a Grade 3 strain generally indicates a severe tear rather than a minor pull, which in turn usually affects both short-term mobility and the ability to ramp up hitting and base running quickly.

According to the report cited by MLB Trade Rumors, Jon Heyman of The New York Post described the diagnosis as a Grade 3 hip flexor strain, and MLBTR characterized it as the highest severity level. MLBTR also reported that the injury could keep Semien out for well over a month, which would represent more than a routine day-to-day absence.

The Mets have not publicly confirmed the medical details in the reporting referenced by MLBTR. That caveat is important for how quickly roster plans can be treated as final, because teams often adjust timelines when they receive updated information from team medical staff or when additional tests refine severity and return-to-play targets.

For New York, Semien is more than a regular at second base. As a veteran presence in the infield, his absence changes how managers balance infield innings, lineup construction, and in-game decisions like double-play alignments and ground-ball handling. In practical terms, the team would need to find at-bats and fielding reps for a replacement, while managing the rhythm of whoever absorbs the bulk of second base duties.

A hip flexor issue also carries a baseball-specific impact. The hip flexor is heavily involved in sprint mechanics, first-step explosiveness, and the lower-body timing that supports bat speed. Even for players who can eventually run, a return that starts with limited activity often requires careful progression to avoid setback, especially late in the season when workload management becomes more sensitive.

This development arrives at a time when teams are typically trying to maintain continuity with their everyday core. If Semien’s time away becomes as prolonged as the report suggests, New York’s options may include shifting internal infield roles, increasing the number of innings for a secondary infielder, and using more frequent lineup reshuffling to cover matchups.

What to watch next is whether the Mets provide an official update on Semien’s status, including whether there is a more specific timeline. Another key point will be how quickly the team can stabilize infield assignments and how the replacement(s) perform in both defense and at-bats, because extended absences often reveal whether a team has adequate depth.

For now, the only firmly stated element in the available reporting is the reported diagnosis and the expectation of extended time out. Until New York confirms details through official channels, the situation should be treated as provisional, with further clarity likely to come as the Mets define a return-to-play plan.